Pathological Gambling: Biological and Clinical Considerations
- PMID: 20161094
- PMCID: PMC2744972
- DOI: 10.1097/ADM.0b013e31819b7bff
Pathological Gambling: Biological and Clinical Considerations
Abstract
Pathological gambling (PG) is categorized as an impulse control disorder (ICD). Phenomenological, neurobiological and pharmacological data suggest similarities in the pathophysiologies of substance use disorders (SUDs) and PG. Both behavioral and pharmacological approaches, including those that have been empirically validated for SUDs, have shown promise in the treatment of PG. Findings from biological studies of PG are reviewed, and treatment approaches based on controlled studies are summarized.
References
-
- American Psychiatric Association Committee on Nomenclature and Statistics . Diagnostic and Statistical Manual of Mental Disorders. 3rd Ed. American Psychiatric Association; Washington, DC: 1980.
-
- American Psychiatric Association Committee on Nomenclature and Statistics . Diagnostic and Statistical Manual of Mental Disorders. 4th Ed American Psychiatric Association; Washington, DC: 1994.
-
- Bechara A. Risky business: Emotion, decision-making, and addiction. J Gambling Stud. 2003;19:23–51. - PubMed
-
- Bergh C, Eklund T, Sodersten P, Nordin C. Altered dopamine function in pathological gambling. Psychol Med. 1997;27:473–475. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources